Investor · 1 deal
Every published round Airtree’s Daniel Petre took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Psylo | Unnamed stage | 1 Oct 2021 | $1.1m | Participant | Startup Daily (Tue 4 Jun 2024), Startup Daily (Thu 27 Oct 2022), Startup Daily (Fri 1 Oct 2021) |
Companies Airtree’s Daniel Petre has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Psylo | 1 Oct 2021 | 1 | 0 |
Fund closes reported for Airtree’s Daniel Petre, as distinct from the investments it has made.
Companies Airtree’s Daniel Petre has backed that another company then bought. An exit for the holding, not a deal Airtree’s Daniel Petre did.
Stories naming Airtree’s Daniel Petre. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.